Form D · Other
MEDIZONE INTERNATIONAL INC
Sausalito, CA · CIK 0000753772
Offering snapshot reported Jul 18, 2012 · SEC filing
- Reported sold
- $109K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 18, 2012 | Initial | $108,500 | No comparison | 2 | SEC filing |
| Nov 15, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 30, 2010 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181412
THE COMPANY PLANS TO SELL UP TO 25,000,000 SHARES OF ITS RESTRICTED COMMON STOCK.
Source: Form D, filed Jul 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Auger | Executive |
| Tommy Auger | Executive |
| Steve Hanni | Executive |
| Daniel Hoyt | Director |
| Edwin Marshall | Director, Executive |
| Michael Shannon | Director |
| Richard Solomon | Director |
Issuer details
Industry: Other (See others in industry)
Address:
4000 Bridgeway Suite 401
Sausalito, CA, 94965
Sausalito, CA, 94965